Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Conditions

Dupuytren Contracture 4Contracture 1Connective Tissue Diseases 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × xiapex × Clear all
NCT03192020 2026-04-29

DETECT

Tampere University

Phase 4 Active not recruiting
302 enrolled

Connective Tissue Diseases, Contracture, Dupuytren Contracture

NCT02647619 2022-04-26

Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

University Hospital, Akershus

Phase 4 Completed
80 enrolled

Dupuytren Contracture

NCT01538017 2016-10-04

Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture

Regionshospitalet Silkeborg

Phase NA Completed
50 enrolled

Dupuytren Contracture

NCT02476461 2015-06-19

PNFvsxiapex

Oslo University Hospital

Phase 4 Unknown
50 enrolled

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡